{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:13:01Z","timestamp":1792804381331,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.arcmed.2014.11.013","type":"journal-article","created":{"date-parts":[[2014,11,25]],"date-time":"2014-11-25T23:32:16Z","timestamp":1416958336000},"page":"687-697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":345,"title":["Role of the Blood\u2013Brain Barrier in Multiple Sclerosis"],"prefix":"10.1016","volume":"45","author":[{"given":"Genaro Gabriel","family":"Ortiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferm\u00edn Paul","family":"Pacheco-Mois\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Mac\u00edas-Islas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Javier","family":"Flores-Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario A.","family":"Mireles-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika Daniela","family":"Gonz\u00e1lez-Renovato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Elizabeth","family":"Hern\u00e1ndez-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e9lica Lizeth","family":"S\u00e1nchez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mois\u00e9s Alejandro","family":"Alatorre-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2014.11.013_bib1","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1016\/j.febslet.2011.04.006","article-title":"Enviromental triggers of multiple sclerosis","volume":"585","author":"Kakalacheva","year":"2011","journal-title":"FEBS Lett"},{"key":"10.1016\/j.arcmed.2014.11.013_bib2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.clim.2013.03.014","article-title":"Role of puberty in multiple sclerosis risk and course","volume":"149","author":"Chitnis","year":"2013","journal-title":"Clin Immunol"},{"key":"10.1016\/j.arcmed.2014.11.013_bib3","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S1474-4422(08)70192-3","article-title":"B cells and multiple sclerosis","volume":"7","author":"Franciotta","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.arcmed.2014.11.013_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04143.x","article-title":"T cells in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"162","author":"Fletcher","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.arcmed.2014.11.013_bib5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.clineuro.2004.02.018","article-title":"The initiation of the autoimmune response in multiple sclerosis","volume":"106","author":"Markovic-Plese","year":"2004","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.arcmed.2014.11.013_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/135245859700300213","article-title":"Remyelination in multiple sclerosis","volume":"3","author":"Lassmann","year":"1997","journal-title":"Mult Scler"},{"key":"10.1016\/j.arcmed.2014.11.013_bib7","doi-asserted-by":"crossref","first-page":"e1000369","DOI":"10.1371\/journal.pgen.1000369","article-title":"Expression of the multiple sclerosis-associated MHC class II allele HLA-DRB1*1501 is regulated by vitamin D","volume":"5","author":"Ramagopalan","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1016\/j.arcmed.2014.11.013_bib8","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nri3265","article-title":"The anatomical and cellular basis of immune surveillance in the central nervous system","volume":"12","author":"Ransohoff","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"488","key":"10.1016\/j.arcmed.2014.11.013_bib9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nature11337","article-title":"T cells become licensed in the lung to enter the central nervous system","volume":"30","author":"Odoardi","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2014.11.013_bib10","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00109-009-0488-6","article-title":"Functions of lipid raft membrane microdomains at the blood-brain barrier","volume":"87","author":"Dodelet-Devillers","year":"2009","journal-title":"J Mol Med"},{"key":"10.1016\/j.arcmed.2014.11.013_bib11","first-page":"252","article-title":"Drug delivery to the central nervous system: a review","volume":"62","author":"Shrenik","year":"2003","journal-title":"J\u00a0Pharm Pharm Sci"},{"key":"10.1016\/j.arcmed.2014.11.013_bib12","first-page":"1","article-title":"Drug delivery systems, CNS protection, and the blood brain barrier","volume":"2014","author":"Upadhyay","year":"2014","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.arcmed.2014.11.013_bib13","first-page":"1","article-title":"Transport mechanisms at the blood-cerebrospinal-fluid barrier: role of megalin (LRP2)","volume":"4","author":"Spuch","year":"2010","journal-title":"Recent Patents Endocr Metab Immune Drug Disc"},{"key":"10.1016\/j.arcmed.2014.11.013_bib14","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1172\/JCI30230","article-title":"Microglia: a cellular vehicle for CNS gene therapy","volume":"116","author":"Herald","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.arcmed.2014.11.013_bib15","first-page":"165","article-title":"The blood-brain barrier and the drug delivery in the central nervous system","volume":"51","author":"Loch-Neckel","year":"2010","journal-title":"Rev Neurol"},{"key":"10.1016\/j.arcmed.2014.11.013_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.addr.2006.01.003","article-title":"Tight junction modulation and its relationship to drug delivery","volume":"58","author":"Salama","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.arcmed.2014.11.013_bib17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jns.2013.03.002","article-title":"Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination","volume":"333","author":"Rostami","year":"2013","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.arcmed.2014.11.013_bib18","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s40265-013-0146-8","article-title":"Promoting remyelination in multiple sclerosis\u2014recent advances","volume":"73","author":"Jolanda","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.arcmed.2014.11.013_bib19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.nicl.2013.12.001","article-title":"Abnormal blood\u2013brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI","volume":"4","author":"Cramer","year":"2014","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.arcmed.2014.11.013_bib20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1126\/science.7624779","article-title":"Induction of MHC class I genesin neurons","volume":"269","author":"Neumann","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.arcmed.2014.11.013_bib21","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1471-4159.2006.04270.x","article-title":"Immune tolerance and control of CNS autoimmunity: from animal models to MS patients","volume":"100","author":"Cassan","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.arcmed.2014.11.013_bib22","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1007\/s00018-008-8059-5","article-title":"Astrocytes in multiple sclerosis: a product of their environment","volume":"65","author":"Nair","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.arcmed.2014.11.013_bib23","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1172\/JCI41911","article-title":"Trafficking of immune cells in the central nervous system","volume":"120","author":"Wilson","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.arcmed.2014.11.013_bib24","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0300-8932(09)71035-8","article-title":"Molecular basis of leukocyte\u2013endothelium interactions during the inflammatory response","volume":"62","author":"Barreiro","year":"2009","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.arcmed.2014.11.013_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/413465","article-title":"Initial immunopathogenesis of multiple sclerosis: innate immune response","volume":"2013","author":"Hern\u00e1ndez-Pedro","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.arcmed.2014.11.013_bib26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bbadis.2010.06.017","article-title":"Disruption of central nervous system barriers in multiple sclerosis","volume":"1812","author":"Alvarez","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.arcmed.2014.11.013_bib27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bbadis.2010.07.019","article-title":"The blood-brain barrier, chemokines and multiple sclerosis","volume":"1812","author":"Holmana","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.arcmed.2014.11.013_bib28","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s00702-013-1079-9","article-title":"Is MS an inflammatory or primary degenerative disease?","volume":"120","author":"Losy","year":"2013","journal-title":"J Neural Transm"},{"key":"10.1016\/j.arcmed.2014.11.013_bib29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10867-009-9157-9","article-title":"Astrocyte\u2013neuron interactions in neurological disorders","volume":"35","author":"Ricci","year":"2009","journal-title":"J Biol Phys"},{"key":"10.1016\/j.arcmed.2014.11.013_bib30","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1189\/jlb.1010550","article-title":"Nitric oxide and redox mechanisms in the immune response","volume":"89","author":"Wink","year":"2011","journal-title":"J Leukocyte Biol"},{"key":"10.1016\/j.arcmed.2014.11.013_bib31","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10875-008-9236-x","article-title":"Multiple sclerosis and regulatory T cells","volume":"6","author":"Costantino","year":"2008","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.arcmed.2014.11.013_bib32","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1126\/science.1148536","article-title":"Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells","volume":"318","author":"Anderson","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.arcmed.2014.11.013_bib33","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/jcbfm.2011.197","article-title":"Neurological diseases in relation to the blood\u2013brain barrier","volume":"32","author":"Rosenberg","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.arcmed.2014.11.013_bib34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1083\/jcb.153.2.263","article-title":"Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells","volume":"153","author":"Furuse","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1016\/j.arcmed.2014.11.013_bib35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1749-6632.2000.tb05235.x","article-title":"The structure and function of claudins, cell adhesion molecules at tight junctions","volume":"915","author":"Tsukita","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.arcmed.2014.11.013_bib36","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1083\/jcb.141.7.1539","article-title":"Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin","volume":"141","author":"Furuse","year":"1998","journal-title":"J Cell Biol"},{"key":"10.1016\/j.arcmed.2014.11.013_bib37","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s004010000180","article-title":"Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme","volume":"100","author":"Liebner","year":"2000","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.arcmed.2014.11.013_bib38","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00401-003-0688-z","article-title":"Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme","volume":"105","author":"Wolburg","year":"2003","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.arcmed.2014.11.013_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4161\/tisb.24782","article-title":"Regulation of claudins in blood-tissue barriers under physiological and pathological states","volume":"1","author":"Gon\u00e7alves","year":"2013","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.arcmed.2014.11.013_bib40","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00401-011-0883-2","article-title":"Claudin-1 induced sealing of blood-brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis","volume":"122","author":"Friederike","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.arcmed.2014.11.013_bib41","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/j.1471-4159.1992.tb10990.x","article-title":"Reactive oxygen species and the central nervous system","volume":"59","author":"Halliwell","year":"1992","journal-title":"J Neurochem"},{"key":"10.1016\/j.arcmed.2014.11.013_bib42","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1089\/neu.2000.17.871","article-title":"Free radical pathways in CNS injury","volume":"17","author":"L\u00e9wen","year":"2000","journal-title":"Neurotrauma"},{"key":"10.1016\/j.arcmed.2014.11.013_bib43","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2174\/1568010054526359","article-title":"Nitric oxide production and signaling in inflammation","volume":"4","author":"Korhonen","year":"2005","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"10.1016\/j.arcmed.2014.11.013_bib44","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.expneurol.2011.03.004","article-title":"Proinflammatory cytokines intensify the activation of NO\/NOS, JNK1\/2 and caspase cascades in immature neurons exposed to elevated levels of unconjugated bilirubin","volume":"229","author":"Vaz","year":"2011","journal-title":"Exp Neurol"},{"key":"10.1016\/j.arcmed.2014.11.013_bib45","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0165-5728(92)90134-7","article-title":"Inflammatory mediators in demyelinating disorders of the CNS and PNS","volume":"40","author":"Hartung","year":"1992","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.arcmed.2014.11.013_bib46","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.neuropharm.2010.04.005","article-title":"Oxidative stress in Alzheimer disease: a possibility for prevention","volume":"59","author":"Bonda","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arcmed.2014.11.013_bib47","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/156720512800107618","article-title":"The role of ER stress-induced apoptosis in neurodegeneration","volume":"9","author":"Stefani","year":"2012","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.arcmed.2014.11.013_bib48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1155\/2009\/325847","article-title":"Oxidative stress is increased in serum from Mexican patients with relapsing-remitting multiple sclerosis","volume":"26","author":"Ortiz","year":"2009","journal-title":"Dis Markers"},{"key":"10.1016\/j.arcmed.2014.11.013_bib49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1750-3639.1999.tb00212.x","article-title":"Demyelination: the role of reactive oxygen and nitrogen species","volume":"9","author":"Smith","year":"1999","journal-title":"Brain Pathol"},{"key":"10.1016\/j.arcmed.2014.11.013_bib50","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jnr.10408","article-title":"Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels","volume":"70","author":"Calabrese","year":"2002","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.arcmed.2014.11.013_bib51","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jneuroim.2004.02.005","article-title":"Inducible nitric oxide synthase in chronic active multiple sclerosis plaques: distribution, cellular expression and association with myelin damage","volume":"151","author":"Hill","year":"2004","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.arcmed.2014.11.013_bib52","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1096\/fj.00-0881fje","article-title":"Reactive oxygen species enhance the migration of monocytes across the blood\u2013brain barrier in\u00a0vitro","volume":"15","author":"van der Goes","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.arcmed.2014.11.013_bib53","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.4049\/jimmunol.177.4.2630","article-title":"Lipoic acid affects cellular migration into the central nervous system and stabilizes blood\u2013brain barrier integrity","volume":"177","author":"Schreibelt","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.arcmed.2014.11.013_bib54","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0165-5728(98)00175-1","article-title":"Reactive oxygen species are required for the phagocytosis of myelin by macrophages","volume":"92","author":"van der Goes","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.arcmed.2014.11.013_bib55","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.bcp.2003.10.018","article-title":"Dietary compounds prevent oxidative damage and nitric oxide production by cells involved in demyelinating disease","volume":"67","author":"van Meeteren","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.arcmed.2014.11.013_bib56","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.brainresrev.2004.12.008","article-title":"Macrophages and neurodegeneration","volume":"48","author":"Hendriks","year":"2005","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.arcmed.2014.11.013_bib57","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/135245859800400323","article-title":"The potential role of nitric oxide in multiple sclerosis","volume":"4","author":"Giovannoni","year":"1998","journal-title":"Mult Scler"},{"key":"10.1016\/j.arcmed.2014.11.013_bib58","doi-asserted-by":"crossref","first-page":"12041","DOI":"10.1073\/pnas.92.26.12041","article-title":"Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis","volume":"92","author":"Bagasra","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.arcmed.2014.11.013_bib59","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1152\/ajpcell.2001.281.6.C1940","article-title":"H(2)O(2)-mediated permeability II: importance of tyrosine phosphatase and kinase activity","volume":"281","author":"Kevil","year":"2001","journal-title":"Am J Physiol, Cell Physiol"},{"key":"10.1016\/j.arcmed.2014.11.013_bib60","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/01.ATV.20.10.2175","article-title":"Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology","volume":"20","author":"Griendling","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.arcmed.2014.11.013_bib61","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1749-6632.2002.tb04675.x","article-title":"Multiple redox regulation of the cellular signaling system linked to AP-1 and NFkappaB: effects of N-acetylcysteine and H2O2 on the receptor tyrosine kinases, the MAP kinase cascade, and IkappaB kinases","volume":"973","author":"Kamata","year":"2002","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.arcmed.2014.11.013_bib62","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0165-5728(01)00329-0","article-title":"Role of poly(ADP-ribose) synthetase activation in the development of experimental allergic encephalomyelitis","volume":"117","author":"Scott","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.arcmed.2014.11.013_bib63","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1474-4422(02)00102-3","article-title":"The role of nitric oxide in multiple sclerosis","volume":"1","author":"Smith","year":"2002","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.arcmed.2014.11.013_bib64","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0026-895X(24)12863-5","article-title":"Phosphorylation of blood vessel vasodilator stimulated phosphoprotein at serine 239 as a functional biochemical marker of endothelial nitric oxide\/cyclic GMP signaling","volume":"61","author":"Ibarra-Alvarado","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.arcmed.2014.11.013_bib65","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/152308601300185179","article-title":"Mechanisms of the antioxidant effects of nitric oxide","volume":"3","author":"Wink","year":"2001","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.arcmed.2014.11.013_bib66","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/glia.10168","article-title":"Cytokine stimulated inducible nitric oxide synthase expression in astroglia: role of Erk mitogen-activated protein kinase and NF-kappaB","volume":"41","author":"Marcus","year":"2003","journal-title":"Glia"},{"key":"10.1016\/j.arcmed.2014.11.013_bib67","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2202-12-40","article-title":"The role of shear stress in blood-brain barrier endothelial physiology","volume":"12","author":"Cucullo","year":"2011","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.arcmed.2014.11.013_bib68","first-page":"38","article-title":"Natalizumab: overview of its pharmacology and safety","volume":"7","author":"Baker","year":"2007","journal-title":"Rev Gastroenterol Disord"},{"key":"10.1016\/j.arcmed.2014.11.013_bib69","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1155\/2013\/238428","article-title":"Nanoparticles for brain drug delivery","volume":"2013","author":"Masserini","year":"2013","journal-title":"ISRN Biochem"},{"key":"10.1016\/j.arcmed.2014.11.013_bib70","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1208\/s12248-008-9018-7","article-title":"Recent advances in blood-brain barrier disruption as a CNS delivery strategy","volume":"10","author":"Bellavance","year":"2008","journal-title":"AAPS J"},{"key":"10.1016\/j.arcmed.2014.11.013_bib71","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood-brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.arcmed.2014.11.013_bib72","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/713714452","article-title":"Drug transport into the mammalian brain: the nasal pathway and its specific metabolic barrier","volume":"10","author":"Minn","year":"2002","journal-title":"J Drug Target"},{"key":"10.1016\/j.arcmed.2014.11.013_bib73","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jneuroim.2004.02.011","article-title":"Intranasal administration of interferon beta bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis","volume":"151","author":"Ross","year":"2004","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.arcmed.2014.11.013_bib74","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature13324","article-title":"Mfsd2a is critical for the formation and function of the blood-brain barrier","volume":"509","author":"Ben-Zvi","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2014.11.013_bib75","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1042\/bj2510763","article-title":"Investigation of endosomal compartments involved in endocytosis and transcytosis of polymeric immunoglobulin a by subcellular fractionation of perfused isolated rat liver","volume":"25","author":"Perez","year":"1988","journal-title":"Biochem J"},{"key":"10.1016\/j.arcmed.2014.11.013_bib76","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000109933","article-title":"Natalizumab: targeting alpha4-integrins in multiple sclerosis","volume":"5","author":"Engelhardt","year":"2008","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.arcmed.2014.11.013_bib77","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nrd1752","article-title":"Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab","volume":"4","author":"Steinman","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.arcmed.2014.11.013_bib78","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jns.2006.04.011","article-title":"Thinking without thinking about natalizumab and PML","volume":"259","author":"Ransohoff","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.arcmed.2014.11.013_bib79","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s000110050742","article-title":"Effects of tetracyclines on the production of matrix metalloproteinases and plasminogen activators as well as of their natural inhibitors, tissue inhibitor of metalloproteinases-1 and plasminogen activator inhibitor-1","volume":"50","author":"Sadowski","year":"2001","journal-title":"Inflamm Res"},{"key":"10.1016\/j.arcmed.2014.11.013_bib80","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1212\/WNL.60.1.52","article-title":"IFNbeta lowers MMP-9\/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS","volume":"60","author":"Waubant","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.arcmed.2014.11.013_bib81","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/archneur.59.5.774","article-title":"Methylprednisolone acts on peripheral blood mono-nuclear cells and endothelium in inhibiting migration phenomena in patients with multiple sclerosis","volume":"59","author":"Gelati","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.arcmed.2014.11.013_bib82","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.plefa.2008.12.001","article-title":"Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis","volume":"80","author":"Shinto","year":"2009","journal-title":"Prostaglandins Leukot Essent Fatty Acids"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440914002628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440914002628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:43:32Z","timestamp":1759261412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440914002628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":82,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0188440914002628"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2014.11.013","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of the Blood\u2013Brain Barrier in Multiple Sclerosis","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2014.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}